Cobalt-catalyzed enantioselective reductive addition of ketimine with cyclopropyl chloride to construct chiral amino esters bearing cyclopropyl fragments

Jiangtao Hu a, Tingting Xia a, Xianqing Wu a, Hongrui Feng a, Jingping Qu a and Yifeng Chen *abc
aKey Laboratory for Advanced Materials and Joint International Research Laboratory of Precision Chemistry and Molecular Engineering, Feringa Nobel Prize Scientist Joint Research Center, Frontiers Science Center for Materiobiology and Dynamic Chemistry, School of Chemistry and Molecular Engineering, East China University of Science and Technology, 130 Meilong Road, Shanghai, 200237, China. E-mail: yifengchen@ecust.edu.cn
bState Key Laboratory of Organometallic Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, Shanghai 200032, China
cSchool of Chemistry and Chemical Engineering, Henan Normal University, Xinxiang, 453007, China

Received 11th August 2024 , Accepted 20th September 2024

First published on 26th September 2024


Abstract

Chiral amino acid derivatives containing cyclopropyl fragments are high-value drug candidates, but their synthesis is still challenging. We herein report an efficient construction of chiral α-tertiary amino acid derivatives containing cyclopropane fragments, which has been achieved via a cobalt-catalyzed asymmetric reductive addition of α-iminoesters with cyclopropyl chloride. This strategy enables the formation of these valuable motifs with broad functional group tolerance under mild conditions with good yields and excellent enantioselectivities.


Introduction

Since the discovery of (+)-trans-chrysanthemic acid by Staudinger and Ruzicka in 1924,1 the development of cyclopropyl-containing natural products and pharmaceutical molecules has gained significant attention in the realm of medicinal chemistry.2 In the meantime, a large number of cyclopropyl-containing natural products have been isolated from various sources.3 Therefore, notable progress has been achieved for the construction of cyclopropane and its application in the total synthesis of cyclopropyl-containing natural products and drug molecules.4 In particular, cyclopropyl group embedded α-amino acid derivatives represent an attractive class of substructure motifs in a broad spectrum of biologically active small molecules (Scheme 1a).5 The existence of the cyclopropyl group in pharmaceuticals would enhance drug efficacy, increase metabolic stability, and increase lipid solubility.6 Given the value and importance of the cyclopropane fragment, considerable efforts have been devoted to developing the highly effective and enantioselective synthesis of cyclopropyl-containing compounds.7 Among various known synthetic methods, the direct introduction of pre-existing cyclopropyl rings is an attractive strategy via transition metal-catalyzed cross-coupling by utilizing cyclopropyl nucleophiles or cyclopropyl electrophiles.8 Notably, reductive cross-coupling between two electrophiles could circumvent the use of unstable organometallic reagents and has garnered increasing interest recently.9–14 In 2020, Rousseaux15 and Weix16 (Scheme 1b) disclosed nickel-catalyzed decarboxylative reductive coupling using cyclopropyl redox-active esters and aryl halides as electrophilic reagents to obtain the corresponding cyclopropyl arylation products. In sharp contrast, leveraging the cyclopropanyl-containing electrophiles in enantioselective transformations remains elusive.
image file: d4qo01474j-s1.tif
Scheme 1 Examples of chiral α-cyclopropane amino acids and the synthesis of cyclopropyl compounds.

Recently, our group has disclosed the Earth-abundant cobalt-catalyzed asymmetric aza-Barbier reaction of α-amino esters with organoelectrophiles as addition fragments to construct α,α-disubstituted amino esters with exceptional enantioselectivities.17 This enantioselective reductive addition protocol could circumvent the use of organometallic reagents, thus enabling a broad substrate scope, especially for those functionalities that are not compatible with organometallic reagents. Based on our group's continuing research interest in asymmetric catalysis,17,18 we herein report our recent progress in cobalt-catalyzed asymmetric reductive addition of ketimines19 with the use of cyclopropyl chloride as the coupling component, thus allowing the expedient construction of chiral amino acid derivatives bearing this pre-existing cyclopropyl ring with excellent enantioselectivities (Scheme 1c).

Our study began with the use of α-imino ester 1a as a model substrate and cyclopropyl chloride 2a as the coupling component to test the feasibility of this asymmetric reductive addition protocol as shown in Table 1.

Table 1 Optimization of the reaction conditionsa

image file: d4qo01474j-u1.tif

Entry Ligand Reductant Temp. (°C) Yieldd (%) eee (%)
a Reaction conditions: 1a (0.1 mmol), 2a (0.15 mmol, 1.5 equiv.), CoI2 (10 mol%), ligand (12 mol%), EtOH (0.1 mmol, 1.0 equiv.), reductant (0.2 mmol, 2.0 equiv.), MeCN (0.2 M) at temperature for 20 h. b Without EtOH. c 5 mol% CoI2 and 6 mol% ligand were used. d Yields determined by NMR using CH2Br2 as an internal standard. e ee values were determined by chiral HPLC. f Isolated yield.
1 L1 Mn 35 43 99
2 L1 Zn 35 30 99
3 L1 In 35 24 99
4b L1 Mn 35 16 99
5 L1 In 50 80 99
6 L1 In 80 84 97
7 L2 In 50 83 (78) 99
8 L3 In 50 57 97
9 L4 In 50 80 97
10 L5 In 50 69 99
11 L2 Mn 50 70 99
12c L2 In 50 70 99
image file: d4qo01474j-u2.tif


The desired amino ester product 3a could be obtained in 43% yield with 99% ee by the utilization of CoI2 and NPN ligand L1 as a catalyst,20 Mn as a reductant and EtOH as an additive in MeCN at 35 °C (Table 1, entry 1). Using zinc or indium as the terminal reductant resulted in yields of 30% and 24% respectively, albeit without affecting the enantioselectivity (Table 1, entries 2 and 3). When the ethanol additive was omitted, the reaction efficiency decreased significantly, leading to a lower yield (Table 1, entry 4). Although the yield was low with indium, the conversion rate of ketimine 1a was also relatively low (see the ESI for details). Increasing the reaction temperature to 50 °C with In as the reductant resulted in a dramatic improvement in the yield (80%, 99% ee), while on increasing the reaction temperature to 80 °C, the yield was improved but the enantioselectivity slightly decreased to 97% ee (Table 1, entries 5 and 6). The screening of chiral ligands was subsequently executed under the aforementioned conditions. Changing the isobutyl group on the chiral oxazoline moiety to other groups such as sec-butyl (L2), tert-butyl (L3), isopropyl (L4), and phenyl (L5) all led to high enantioselectivity (Table 1, entries 7–10). In particular, the employment of the isobutyl substituted NPN ligand L2 further improved the yield to 83% (78% isolated yield) with 99% ee (Table 1, entry 7). These conditions were determined to be optimal. However, replacing the reductant with manganese powder or reducing the catalyst loading led to a decrease in the yield (Table 1, entries 11 and 12).

With the optimized conditions in hand, we investigated the substrate scope for the enantioselective reductive addition of ketimines to construct chiral amino acids containing cyclopropane fragments (Scheme 2). The reaction efficiency varied with different ester groups on the imine substrate, including methyl (3b), ethyl (3a), and isopropyl (3k), affording the corresponding products in 78–90% yields with excellent 99% ee. The scope of the aryl groups on imines was also examined, with high yields and enantioselectivities observed for various substituents, such as naphthalene (3c), pepper rings (3d), and halogens like chlorine (3e) and fluorine (3f) on the benzene ring. These substituents had no adverse effects on the reaction yield or enantioselectivity. For heterocyclic-substituted imines like thiophene, product 3g was obtained in 55% yield with 99% ee. Evaluation of the substitution pattern of the aromatic ring on the nitrogen atom moiety revealed that both electron-rich substitution (3h) and steric hindrance (3i) would not affect the yield and enantioselectivity. Furthermore, when the phenyl group was replaced with a methyl group, the reaction still obtained the product (3j) in 46% yield with 99% ee.


image file: d4qo01474j-s2.tif
Scheme 2 Substrate scope. Reaction conditions: 1 (0.1 mmol), 2 (0.15 mmol, 1.5 equiv.), CoI2 (10 mol%), L2 (12 mol%), R2OH (0.1 mmol, 1.0 equiv.), In (0.2 mmol, 2.0 equiv.), MeCN (0.2 M) at 50 °C for 20 h. a[thin space (1/6-em)]Extend the reaction time to 40 hours.

Next, we explored the applicability of cyclopropyl chloride electrophiles to afford amino esters with excellent enantioselectivities (3k–3t). For substrates with large sterically hindered substituents on the benzene ring, including tert-butyl (3l) and phenyl (3m), the reaction yield and enantioselectivity were not significantly affected. Encouragingly, both electron-donating groups (–OR) and electron-withdrawing halogen atoms (–Cl) were successfully incorporated into the substrate, leading to the corresponding products in excellent yields with outstanding enantioselectivities (3n, 3o, 3q). Additionally, naphthalene and thiophene groups did not adversely affect the reaction's efficiency or enantioselectivity (3p, 3t). Finally, the introduction of functional groups at the ortho (–Cl) and meta (–OiPr) positions of aryl groups maintained the expected enantioselectivity, although steric hindrance reduced the reaction yield (3r, 3s). The absolute configuration of 3k was determined as R configuration which was confirmed by X-ray diffraction analysis.

To further showcase the potential synthetic utility of the reductive addition protocol for constructing chiral amino acids containing cyclopropane fragments, we performed the following synthetic application (Scheme 3). Firstly, we scaled up the reaction to 3.0 mmol using cyclopropyl chloride 2a and ketimine 1b as substrates under the standard conditions. The desired product 3k was obtained on a gram scale with 86% isolated yield and 99% ee (Scheme 3a). Subsequently, we carried out a series of derivatization experiments. For the chiral product 3b, we used CAN to remove the PMP group, successfully obtaining compound 4 in 95% yield with 99% ee. Following this, the methyl ester was hydrolyzed using LiOH to obtain amino acid 5 in 96% yield. Moreover, treating 3k with LiAlH4 allowed us to efficiently obtain amino alcohol 6 in 94% yield without compromising the enantioselectivity. Subsequently, alcohol 6 was cyclized using the Mitsunobu reaction, resulting in the bicyclic product 7 in 77% yield with 95% ee (Scheme 3b).


image file: d4qo01474j-s3.tif
Scheme 3 Synthetic application.

On the basis of the previous research on the Co-catalyzed reductive addition of ketimine, we proposed the following plausible mechanism (Scheme 4). First, the reaction is initiated by the generation of the LCo(I) species utilizing In as the reductant. The active LCo(I) species coordinates with imine substrate 1a to afford the Co(I) species int A, which immediately undergoes a SET process with cyclopropyl chloride 2a to produce int B and the cyclopropyl radical. The cyclopropyl radical could combine with Co(II) of int B to generate the Co(III) species int C, followed by reduction to give int D. A subsequent enantioselective migratory insertion to the C[double bond, length as m-dash]N double bond of int D generates int E (path a), which finally releases product 3a and regenerates int A by protonation, ligand exchange and a reduction process. Alternatively, the cyclopropyl radical could also undergo enantioselective radical addition to the C[double bond, length as m-dash]N double bond of int B to generate the Co(III) species int C′ followed by reduction with In to afford int E (path b), which could release product 3a and regenerate int A in the same way as mentioned above.


image file: d4qo01474j-s4.tif
Scheme 4 Proposed mechanism.

Conclusions

In conclusion, we disclose a cobalt-catalyzed asymmetric reductive addition reaction of cyclopropyl chloride with α-imino esters under mild conditions, enabling the efficient construction of chiral α-tertiary amino acid derivatives containing cyclopropane fragments. This method exhibits excellent enantioselectivity, good functional group tolerance, broad substrate scope and ease of scale-up. Further exploration of this reductive addition is currently ongoing in our group.

Author contributions

Jiangtao Hu and Tingting Xia performed most experiments. Hongrui Feng provided assistance in the experiment. Xianqing Wu and Jingping Qu guided the process of the experiment. Yifeng Chen conceived the idea and supervised the research. Tingting Xia and Yifeng Chen co-wrote the manuscript with feedback from all authors.

Data availability

The data supporting this article have been included as part of the ESI.

Conflicts of interest

There are no conflicts to declare.

Acknowledgements

This work was supported by the National Natural Science Foundation of China (22171079, 22371071, 92356301), Sinopec Seeding Program (C0607-0876), Shanghai Municipal Science and Technology Major Project (Grant No.2018SHZDZX03), the Program of Introducing Talents of Discipline to Universities (B16017), Shanghai Sailing Program (23YF1408800) and the Fundamental Research Funds for the Central Universities. The authors thank the Analysis and Testing Center of East China University of Science and Technology for help with NMR and HRMS analysis.

Notes and references

  1. H. Staudinger and L. Ruzicka, Insektentötende Stoffe I. Über Isolierung und Konstitution des Wirksamen Teiles des dalmatinischen Insektenpulvers, Helv. Chim. Acta, 1924, 7, 177–201 CrossRef CAS .
  2. (a) U. R. Patel and J. R. Proudfoot, The synthesis of 11-cyclopropyl-5,11-dihydro-4-(hydroxymethyl)-6H-dipyrido[3,2-b:2′,3′-e][1,4]diazepin-6-one, a putative metabolite of the HIV-1 reverse transcriptase inhibitor nevirapine, J. Org. Chem., 1992, 57, 4023–4025 CrossRef CAS ; (b) W. Haas, C. M. Pillar, G. E. Zurenko, J. C. Lee, L. S. Brunner and T. W. Morris, Besifloxacin, a novel fluoroquinolone, has broad-spectrum In vitro activity against aerobic and anaerobic bacteria, Antimicrob. Agents Chemother., 2009, 53, 3552–3560 CrossRef CAS PubMed ; (c) Å. Rosenquist, B. Samuelsson, P.-O. Johansson, M. D. Cummings, O. Lenz, P. Raboisson, K. Simmen, S. Vendeville, H. de Kock, M. Nilsson, A. Horvath, R. Kalmeijer, G. de la Rosa and M. Beumont-Mauviel, Discovery and development of simeprevir (TMC435), a HCV NS3/4A protease inhibitor, J. Med. Chem., 2014, 57, 1673–1693 CrossRef PubMed ; (d) L. Moni, L. Banfi, A. Basso, L. Carcone, M. Rasparini and R. Riva, Ugi and Passerini reactions of biocatalytically derived chiral aldehydes: application to the synthesis of bicyclic pyrrolidines and of antiviral agent telaprevir, J. Org. Chem., 2015, 80, 3411–3428 CrossRef CAS PubMed ; (e) C. M. Marshall, J. G. Federice, C. N. Bell, P. B. Cox and J. T. Njardarson, An update on the nitrogen heterocycle compositions and properties of U.S. FDA-approved pharmaceuticals (2013-2023), J. Med. Chem., 2024, 67, 11622–11655 CrossRef CAS PubMed .
  3. (a) C. J. Suckling, The cyclopropyl group in studies of enzyme mechanism and Inhibition, Angew. Chem., Int. Ed. Engl., 1988, 27, 537–552 CrossRef ; (b) L. A. Wessjohann, W. Brandt and T. Thiemann, Biosynthesis and metabolism of cyclopropane rings in natural compounds, Chem. Rev., 2003, 103, 1625–1648 CrossRef CAS PubMed ; (c) F. Brackmann and A. de Meijere, Natural occurrence, syntheses, and applications of cyclopropyl-group-containing α-amino acids. 2. 3,4- and 4,5-methanoamino acids, Chem. Rev., 2007, 107, 4538–4583 CrossRef CAS PubMed .
  4. (a) M. A. Cavitt, L. H. Phun and S. France, Intramolecular donor-acceptor cyclopropane ring-opening cyclizations, Chem. Soc. Rev., 2014, 43, 804–818 RSC ; (b) C. Ebner and E. M. Carreira, Cyclopropanation strategies in recent total syntheses, Chem. Rev., 2017, 117, 11651–11679 CrossRef CAS PubMed ; (c) W. Jin, H. Yuan and G. Tang, Ni-catalyzed carbon–carbon bond-forming reductive amination, Chin. J. Org. Chem., 2018, 38, 2324–2334 CrossRef CAS ; (d) V. Pirenne, B. Muriel and J. Waser, Enantioselective synthesis of pyridines with all-carbon quaternary carbon centers via cobalt-catalyzed desymmetric [2+2+2] cycloaddition, Chem. Rev., 2021, 121, 227–263 CrossRef CAS PubMed ; (e) T. R. McDonald, L. R. Mills, M. S. West and S. A. L. Rousseaux, Selective carbon–carbon bond cleavage of cyclopropanols, Chem. Rev., 2021, 121, 3–79 CrossRef CAS PubMed ; (f) B. Fu, L. Wang, K. Chen, X. Yuan, J. Yin, S. Wang, D. Shi, B. Zhu, W. Guan, Q. Zhang and T. Xiong, Enantioselective copper-catalyzed sequential hydrosilylation of arylmethylenecyclopropanes, Angew. Chem., Int. Ed., 2024, e202407391 Search PubMed .
  5. (a) D. Ma and W. Zhu, Synthesis of (S)-α-cyclopropyl-4-phosphonophenylglycine, J. Org. Chem., 2001, 66, 348–350 CrossRef CAS PubMed ; (b) H. R. Hoveyda, E. Marsault, R. Gagnon, A. P. Mathieu, M. Vézina, A. Landry, Z. Wang, K. Benakli, S. Beaubien, C. Saint-Louis, M. Brassard, J.-F. Pinault, L. Ouellet, S. Bhat, M. Ramaseshan, X. Peng, L. Foucher, S. Beauchemin, P. Bhérer, D. F. Veber, M. L. Peterson and G. L. Fraser, Optimization of the potency and pharmacokinetic properties of a macrocyclic ghrelin receptor agonist (part I): development of Ulimorelin (TPZ-101) from hit to clinic, J. Med. Chem., 2011, 54, 8305–8320 CrossRef PubMed ; (c) N. Liu, F. Eshak, F. Malhaire, I. Brabet, L. Prézeau, E. Renard, J.-P. Pin, F. C. Acher, M. Staudt and L. Bunch, Design, synthesis, pharmacology, and in silico studies of (1S,2S,3S)-2-((S)-amino(carboxy)methyl)-3-(carboxymethyl)cyclopropane-1-carboxylic acid (LBG30300): a picomolar potency subtype-selective mGlu2 receptor agonist, J. Med. Chem., 2024, 67, 1314–1326 CrossRef CAS PubMed .
  6. (a) R. D. Taylor, M. MacCoss and A. D. G. Lawson, Rings in drugs, J. Med. Chem., 2014, 57, 5845–5859 CrossRef CAS PubMed ; (b) T. T. Talele, The “cyclopropyl fragment” is a versatile player that frequently appears in preclinical/clinical drug molecules, J. Med. Chem., 2016, 59, 8712–8756 CrossRef CAS PubMed .
  7. (a) S. F. Martin, G. O. Dorsey, T. Gane, M. C. Hillier, H. Kessler, M. Baur, B. Mathä, J. W. Erickson, T. N. Bhat, S. Munshi, S. V. Gulnik and I. A. Topol, Cyclopropane-derived peptidomimetics. Design, synthesis, evaluation, and structure of novel HIV-1 protease inhibitors, J. Med. Chem., 1998, 41, 1581–1597 CrossRef CAS PubMed ; (b) W. A. Donaldson, Synthesis of cyclopropane containing natural products, Tetrahedron, 2001, 57, 8589–8627 CrossRef CAS ; (c) D. Y.-K. Chen, R. H. Pouwer and J.-A. Richard, Recent advances in the total synthesis of cyclopropane-containing natural products, Chem. Soc. Rev., 2012, 41, 4631–4642 RSC ; (d) P. Tang and Y. Qin, Recent applications of cyclopropane-based strategies to natural product synthesis, Synthesis, 2012, 2969–2984 CAS ; (e) Z. Casar, Synthetic approaches to contemporary drugs that contain the cyclopropyl moiety, Synthesis, 2020, 1315–1345 CrossRef CAS .
  8. (a) D. Peters, A.-B. Hörnfeldt and S. Gronowitz, Synthesis of 5-cyclopropyluracil and 5-cyclopropylcytosine by the Pd(0)-catalyzed coupling reaction, J. Heterocycl. Chem., 1991, 28, 1629–1631 CrossRef CAS ; (b) G. A. Molander and P. E. Gormisky, Palladium-catalyzed cross-coupling reaction of tricyclopropylbismuth with aryl halides and triflates, J. Org. Chem., 2008, 73, 7481–7485 CrossRef CAS PubMed ; (c) A. Gagnon, M. Duplessis, P. Alsabeh and F. Barabé, Cross-coupling of cyclopropyl- and cyclobutyltrifluoroborates with aryl and heteroaryl chlorides, J. Org. Chem., 2008, 73, 3604–3607 CrossRef CAS PubMed ; (d) C. Shu, K. Sidhu, L. Zhang, X. Wang, D. Krishnamurthy and C. H. Senanayake, Palladium-catalyzed cross-coupling of cyclopropylmagnesium bromide with aryl bromides mediated by zinc halide additives, J. Org. Chem., 2010, 75, 6677–6680 CrossRef CAS PubMed ; (e) G. A. Molander, F. Beaumard and T. K. Niethamer, Cross-coupling of mesylated phenol derivatives with potassium cyclopropyltrifluoroborate, J. Org. Chem., 2011, 76, 8126–8130 CrossRef CAS PubMed ; (f) S. N. Greszler, G. T. Halvorsen and E. A. Voight, Synthesis of substituted cyclopropanecarboxylates via room temperature palladium-catalyzed α-arylation of Reformatsky reagents, Org. Lett., 2017, 19, 2490–2493 CrossRef CAS PubMed ; (g) C. Andersen, V. Ferey, M. Daumas, P. Bernardelli, A. Guérinot and J. Cossy, Introduction of cyclopropyl and cyclobutyl ring on alkyl iodides through cobalt-catalyzed cross-coupling, Org. Lett., 2019, 21, 2285–2289 CrossRef CAS PubMed ; (h) B. Li, J. Shi and Y. Xia, Diversified synthesis of all-carbon quaternary gem-difluorinated cyclopropanes via copper-catalyzed cross-coupling, Org. Lett., 2023, 25, 2674–2679 CrossRef CAS PubMed ; (i) D. Han, J. Sun and J. Jin, Nickel-catalyzed reductive cross-coupling of aryl bromides with bromocyclopropane and beyond, Chem. – Asian J., 2023, 18, e202201132 CrossRef CAS PubMed ; (j) A. L. Gabbey, K. Scotchburn and S. A. L. Rousseaux, Metal-catalysed C–C bond formation at cyclopropanes, Nat. Rev. Chem., 2023, 7, 548–560 CrossRef CAS PubMed .
  9. (a) C.-H. Wei, S. Mannathan and C.-H. Cheng, Enantioselective synthesis of β-substituted cyclic ketones via cobalt-catalyzed asymmetric reductive coupling of alkynes with alkenes, J. Am. Chem. Soc., 2011, 133, 6942–6944 CrossRef CAS PubMed ; (b) C.-H. Wei, S. Mannathan and C.-H. Cheng, Regio- and enantioselective cobalt-catalyzed reductive [3+2] cycloaddition reaction of alkynes with cyclic enones: a route to bicyclic tertiary alcohols, Angew. Chem., Int. Ed., 2012, 51, 10592–10595 CrossRef CAS PubMed ; (c) Y.-L. Li, S.-Q. Zhang, J. Chen and J.-B. Xia, Highly regio- and enantioselective reductive coupling of alkynes and aldehydes via photoredox cobalt dual catalysis, J. Am. Chem. Soc., 2021, 143, 7306–7313 CrossRef CAS PubMed ; (d) K. Cui, Y.-L. Li, G. Li and J.-B. Xia, Regio- and stereoselective reductive coupling of alkynes and crotononitrile, J. Am. Chem. Soc., 2022, 144, 23001–23009 CrossRef CAS PubMed ; (e) Z.-Y. Gu, W.-D. Li, Y.-L. Li, K. Cui and J.-B. Xia, Selective reductive coupling of vinyl azaarenes and alkynes via photoredox cobalt dual catalysis, Angew. Chem., Int. Ed., 2023, 62, e202213281 CrossRef CAS PubMed ; (f) D. Ding, L. Zhang, H. Wen and C. Wang, Cobalt-catalyzed asymmetric reductive dicarbofunctionalization of 1,3-dienes with o-bromoaryl imines as a bis-electrophile, ACS Catal., 2023, 13, 744–748 CrossRef CAS ; (g) Y. Bao, C. Zheng, K. Xiong, C. Hu, P. Lu, Y. Wang and Z. Lu, Enantioconvergent hydroboration of E/Z-mixed trisubstituted alkenes, J. Am. Chem. Soc., 2024, 146, 21089–21098 CrossRef CAS PubMed ; (h) J. Wang, X. Shen, X. Chen, Y. Bao, J. He and Z. Lu, Cobalt-catalyzed enantioconvergent Negishi cross-coupling of α-bromoketones, J. Am. Chem. Soc., 2023, 145, 24958–24964 CAS .
  10. (a) X. Zhang, J. Wang and S.-D. Yang, Enantioselective cobalt-catalyzed reductive cross-coupling for the synthesis of axially chiral phosphine–olefin ligands, ACS Catal., 2021, 11, 14008–14015 CrossRef CAS ; (b) X. Jiang, W. Xiong, S. Deng, F.-D. Lu, Y. Jia, Q. Yang, L.-Y. Xue, X. Qi, J. A. Tunge, L.-Q. Lu and W.-J. Xiao, Construction of axial chirality via asymmetric radical trapping by cobalt under visible light, Nat. Catal., 2022, 5, 788–797 CrossRef CAS ; (c) Z. Ma, W. Xu, Y.-D. Wu and J. S. Zhou, Cobalt-catalyzed enantioselective cross-electrophile couplings: stereoselective syntheses of 5–7-membered azacycles, J. Am. Chem. Soc., 2023, 145, 16464–16473 CrossRef CAS PubMed ; (d) M. Zhao, L. Zhang and J. S. Zhou, Enantioselective reductive conjugate alkenylation of α,β-unsaturated ketones and amides via nickel catalysis, ACS Catal., 2024, 14, 6228–6235 CrossRef CAS ; (e) S. Huang and J. S. Zhou, Nickel-catalyzed enantioselective reductive arylation of common ketones, J. Am. Chem. Soc., 2024, 146, 12895–12900 CrossRef CAS PubMed ; (f) M. Zhao, W. Xu, Y.-D. Wu, X. Yang, J. Wang and J. S. Zhou, Cobalt-catalyzed enantioselective reductive arylation, heteroarylation, and alkenylation of Michael acceptors via an elementary mechanism of 1,4-addition, J. Am. Chem. Soc., 2024, 146, 20477–20493 CrossRef CAS PubMed .
  11. (a) L. Wang, L. Wang, M. Li, Q. Chong and F. Meng, Cobalt-catalyzed diastereo- and enantioselective reductive allyl additions to aldehydes with allylic alcohol derivatives via allyl radical intermediates, J. Am. Chem. Soc., 2021, 143, 12755–12765 CrossRef CAS PubMed ; (b) L. Wang, C. Lin, Q. Chong, Z. Zhang and F. Meng, Photoredox cobalt-catalyzed regio-, diastereo- and enantioselective propargylation of aldehydes via propargyl radicals, Nat. Commun., 2023, 14, 4825–5839 CrossRef CAS PubMed ; (c) K. E. Berger, R. J. Martinez, J. Zhou and C. Uyeda, Catalytic asymmetric cyclopropanations with nonstabilized carbenes, J. Am. Chem. Soc., 2023, 145, 9441–9447 CrossRef CAS PubMed ; (d) H. D. Bishop, Q. Zhao and C. Uyeda, Catalytic asymmetric synthesis of zinc metallacycles, J. Am. Chem. Soc., 2023, 145, 20152–20157 CrossRef CAS PubMed ; (e) K.-X. Zhang, M.-Y. Liu, B.-Y. Yao, Q.-L. Zhou and L.-J. Xiao, Stereoconvergent and enantioselective synthesis of Z-homoallylic alcohols via nickel-catalyzed reductive coupling of Z/E-1,3-dienes with aldehydes, J. Am. Chem. Soc., 2024, 146(32), 22157–22165 CrossRef CAS PubMed ; (f) C. Lin, J. Zhang, Z. Sun, Y. Guo, Q. Chong, Z. Zhang and F. Meng, Cobalt-catalyzed enantioselective alkenylation of aldehydes, Angew. Chem., Int. Ed., 2024, 63, e202405290 CrossRef CAS PubMed ; (g) H. Wang, X. Jie, Q. Chong and F. Meng, Pathway-divergent coupling of 1,3-enynes with acrylates through cascade cobalt catalysis, Nat. Commun., 2024, 15, 3427–3426 CrossRef CAS PubMed .
  12. (a) X. Jiang, H. Jiang, Q. Yang, Y. Cheng, L.-Q. Lu, J. A. Tunge and W.-J. Xiao, Photoassisted cobalt-catalyzed asymmetric reductive Grignard-type addition of aryl iodides, J. Am. Chem. Soc., 2022, 144, 8347–8354 CrossRef CAS PubMed ; (b) H. Jiang, X.-K. He, X. Jiang, W. Zhao, L.-Q. Lu, Y. Cheng and W.-J. Xiao, Photoinduced cobalt-catalyzed desymmetrization of dialdehydes to access axial chirality, J. Am. Chem. Soc., 2023, 145, 6944–6952 CrossRef CAS PubMed ; (c) S. Zhang, S. Perveen, Y. Ouyang, L. Xu, T. Yu, M. Zhao, L. Wang, P. Song and P. Li, Design and synthesis of tunable chiral 2,2′-bipyridine ligands: application to the enantioselective nickel-catalyzed reductive arylation of aldehydes, Angew. Chem., Int. Ed., 2022, 61, e202117843 CrossRef CAS PubMed ; (d) Z. Zhu, J. Xiao, M. Li and Z. Shi, Nickel-catalyzed intermolecular asymmetric addition of aryl iodides across aldehydes, Angew. Chem., Int. Ed., 2022, 61, e202201370 CrossRef CAS PubMed ; (e) W. Xiong, X. Jiang, W.-C. Wang, Y. Cheng, L.-Q. Lu, K. Gao and W.-J. Xiao, Dynamic kinetic reductive conjugate addition for construction of axial chirality enabled by synergistic photoredox/cobalt catalysis, J. Am. Chem. Soc., 2023, 145, 7983–7991 CrossRef CAS PubMed ; (f) T. Liang, Y. Wu, J. Sun, M. Li, H. Zhao, J. Zhang, G. Zheng and Q. Zhang, Visible light-mediated cobalt and photoredox dual-catalyzed asymmetric reductive coupling for axially chiral secondary alcohols, Chin. J. Chem., 2023, 41, 3253–3260 CrossRef CAS .
  13. (a) J. Xiao, M. Wang, X. Yin, S. Yang, P. Gu, X. Lv, Y. Zhao and Z. Shi, Enantioselective reductive (hetero)arylation of cyclic N-sulfonyl imines by cobalt catalysis, Angew. Chem., Int. Ed., 2023, 62, e202300743 CrossRef CAS PubMed ; (b) L. Zhang, X. Wang, M. Pu, C. Chen, P. Yang, Y.-D. Wu, Y. R. Chi and J. S. Zhou, Nickel-catalyzed enantioselective reductive arylation and heteroarylation of aldimines via an elementary 1,4-addition, J. Am. Chem. Soc., 2023, 145, 8498–8509 CrossRef CAS PubMed ; (c) X.-K. He, L.-Q. Lu, B.-R. Yuan, J.-L. Luo, Y. Cheng and W.-J. Xiao, Desymmetrization–addition reaction of cyclopropenes to imines via synergistic photoredox and cobalt catalysis, J. Am. Chem. Soc., 2024, 146, 18892–18898 CrossRef CAS PubMed ; (d) J. Xiao, Y. Zheng, Y. Zhao, Z. Shi and M. Wang, Asymmetric Nozaki-Hiyama-Kishi (NHK)-type reaction of isatins with aromatic iodides by cobalt catalysis, Chin. Chem. Lett., 2024 DOI:10.1016/j.cclet.2024.110243 .
  14. (a) C. Heinz, J. P. Lutz, E. M. Simmons, M. M. Miller, W. R. Ewing and A. G. Doyle, Ni-catalyzed carbon–carbon bond-forming reductive amination, J. Am. Chem. Soc., 2018, 140, 2292–2300 CrossRef CAS PubMed ; (b) M. Presset, J. Paul, G. N. Cherif, N. Ratnam, N. Laloi, E. Léonel, C. Gosmini and E. L. Gall, CoI-catalyzed Barbier reactions of aromatic halides with aromatic aldehydes and imines, Chem. – Eur. J., 2019, 25, 4491–4495 CrossRef CAS PubMed ; (c) R. F. Turro, M. Brandstätter and S. E. Reisman, Nickel-catalyzed reductive alkylation of heteroaryl imines, Angew. Chem., Int. Ed., 2022, 61, e202207597 CrossRef CAS PubMed ; (d) L. Ding, Y. Zhao, H. Lu, Z. Shi and M. Wang, Nickel-catalyzed asymmetric propargyl-aryl cross-electrophile coupling, Angew. Chem., Int. Ed., 2024, 63, e202313655 CrossRef CAS PubMed .
  15. (a) M. S. West, A. L. Gabbey, M. P. Huestis and S. A. L. Rousseaux, Ni-catalyzed reductive cross-coupling of cyclopropylamines and other strained ring NHP esters with (hetero)aryl halides, Org. Lett., 2022, 24, 8441–8446 CrossRef CAS PubMed ; (b) J. W. Pearson, T. R. Hou, J. Golijanin, P. I. Stewart, E. S. Choi, A. L. Gabbey, M. S. West and S. A. L. Rousseaux, Ni-catalyzed reductive 1,2-alkylarylation of alkenes for the synthesis of spirocyclic γ-lactams, Org. Lett., 2024, 26, 5560–5565 CrossRef CAS PubMed .
  16. D. C. Salgueiro, B. K. Chi, I. A. Guzei, P. García-Reynaga and D. J. Weix, Control of redox-active ester reactivity enables a general cross-electrophile approach to access arylated strained rings, Angew. Chem., 2022, 134, e202205673 CrossRef .
  17. (a) X. Wu, H. Xia, C. Gao, B. Luan, L. Wu, C. Zhang, D. Yang, L. Hou, N. Liu, T. Xia, H. Li, J. Qu and Y. Chen, Modular α-tertiary amino ester synthesis through cobalt-catalysed asymmetric aza-Barbier reaction, Nat. Chem., 2024, 16, 398–407 CrossRef CAS PubMed ; (b) T. Xia, Y. Wu, J. Hu, X. Wu, J. Qu and Y. Chen, Cobalt-catalyzed asymmetric aza-Nozaki-Hiyama-Kishi (NHK) reaction of α-imino esters with alkenyl halides, Angew. Chem., Int. Ed., 2024, 63, e202316012 CrossRef CAS PubMed ; (c) T. Xia, W. Wu, X. Wu, J. Qu and Y. Chen, Cobalt-catalyzed enantioselective reductive α-chloro-carbonyl addition of ketimine to construct the β-tertiary amino acid analogues, Angew. Chem., Int. Ed., 2024, 63, e202318991 CrossRef CAS PubMed ; (d) C. Zhang, X. Wu, J. Qu and Y. Chen, A general enantioselective α-alkyl amino acid derivatives synthesis enabled by cobalt-catalyzed reductive addition, J. Am. Chem. Soc., 2024, 146, 25918–25926 CrossRef CAS PubMed .
  18. (a) W. Huang, Y. Xi, D. Pan, L. Fan, K. Fang, G. Huang, W.-H. Zhu, J. Qu and Y. Chen, Palladium-catalyzed enantioselective multicomponent cross-coupling of trisubstituted olefins, J. Am. Chem. Soc., 2024, 146, 16892–16901 CrossRef CAS PubMed ; (b) C. Wang, Y. Xi, T. Xia, J. Qu and Y. Chen, Pd(0)-catalyzed diastereoselective and enantioselective intermolecular Heck–Miyaura borylation of internal enamides for the β-aminoboronate ester synthesis, ACS Catal., 2024, 14, 418–425 CrossRef CAS ; (c) X. Wu, J. Qu and Y. Chen, Quinim: a new ligand scaffold enables nickel-catalyzed enantioselective synthesis of α-alkylated γ-lactam, J. Am. Chem. Soc., 2020, 142, 15654–15660 CrossRef CAS PubMed ; (d) X. Wu, B. Luan, W. Zhao, F. He, X.-Y. Wu, J. Qu and Y. Chen, Catalytic desymmetric dicarbofunctionalization of unactivated alkenes, Angew. Chem., Int. Ed., 2022, 61, e202111598 CrossRef CAS PubMed ; (e) X. Wu, A. Turlik, B. Luan, F. He, J. Qu, K. N. Houk and Y. Chen, Nickel-catalyzed enantioselective reductive alkyl-carbamoylation of internal alkenes, Angew. Chem., Int. Ed., 2022, 61, e202207536 CrossRef CAS PubMed ; (f) F. He, L. Hou, X. Wu, H. Ding, J. Qu and Y. Chen, Enantioselective synthesis of α-alkenylated γ-lactam enabled by Ni-catalyzed 1,4-arylcarbamoylation of 1,3-dienes, CCS Chem., 2023, 5, 341–349 CrossRef CAS ; (g) C. Zhang, X. Wu, T. Xia, J. Qu and Y. Chen, Ni-catalyzed carbamoylation of unactivated alkenes for stereoselective construction of six-membered lactams, Nat. Commun., 2022, 13, 5964–5972 CrossRef PubMed ; (h) X. Wu, H. Li, F. He, J. Qu and Y. Chen, Nickel/Quinim enabled asymmetric carbamoyl-acylation of unactivated alkenes, Chin. J. Chem., 2023, 41, 1673–1678 CrossRef CAS ; (i) L. Wu, X. Wu, J. Qu and Y. Chen, Exploration of Quinim ligand in Ni-catalyzed enantioselective reductive carbamoyl-alkylation of alkene, Chin. J. Org. Chem., 2023, 43, 4239–4250 CrossRef CAS ; (j) K. Fang, W. Huang, C. Shan, J. Qu and Y. Chen, Synthesis of 3,3-dialkyl-substituted isoindolinones enabled by nickel-catalyzed reductive dicarbofunctionalization of enamides, Org. Lett., 2021, 23, 5523–5527 CrossRef CAS PubMed .
  19. B. Kokić, B. Vulović, M. Jović, A. Andrijević, V. Ajdačić and I. M. Opsenica, Strategies for carbon electrophile addition to carbonyls and imines by cobalt catalysis, Eur. J. Org. Chem., 2023, e202300997 CrossRef .
  20. (a) S. Ghorai, S. S. Chirke, W.-B. Xu, J.-F. Chen and C. Li, Cobalt-catalyzed regio- and enantioselective allylic amination, J. Am. Chem. Soc., 2019, 141, 11430–11434 CrossRef CAS PubMed ; (b) S. Ghorai, S. Ur Rehman, W.-B. Xu, W.-Y. Huang and C. Li, Cobalt-catalyzed regio- and enantioselective allylic alkylation of malononitriles, Org. Lett., 2020, 22, 3519–3523 CrossRef CAS PubMed ; (c) W.-Y. Huang, C.-H. Lu, S. Ghorai, B. Li and C. Li, Regio- and enantioselective allylic alkylation of terminal alkynes by synergistic Rh/Cu catalysis, J. Am. Chem. Soc., 2020, 142, 15276–15281 CrossRef CAS PubMed ; (d) J.-F. Chen and C. Li, Cobalt/bisoxazolinephosphine-catalyzed asymmetric alkynylation of isatins, Org. Lett., 2020, 22, 4686–4691 CrossRef CAS PubMed ; (e) W.-B. Xu, M. Sun, M. Shu and C. Li, Rhodium-catalyzed regio- and enantioselective allylic amination of racemic 1,2-disubstituted allylic phosphates, J. Am. Chem. Soc., 2021, 143, 8255–8260 CrossRef CAS PubMed ; (f) K. Li, L. Wei, M. Sun, B. Li, M. Liu and C. Li, Enantioselective synthesis of pyridines with all-carbon quaternary carbon centers via cobalt-catalyzed desymmetric [2+2+2] cycloaddition, Angew. Chem., Int. Ed., 2021, 60, 20204–20209 CrossRef CAS PubMed ; (g) B. Li, M. Liu, S. U. Rehman and C. Li, Rh-catalyzed regio- and enantioselective allylic phosphinylation, J. Am. Chem. Soc., 2022, 144, 2893–2898 CrossRef CAS PubMed ; (h) M. Sun, L. Wei and C. Li, Regio- and enantioselective allylic cyanomethylation by synergistic rhodium and silane catalysis, J. Am. Chem. Soc., 2023, 145, 3897–3902 CrossRef CAS PubMed ; (i) B. Li, Y. Luo, M. Liu, Y. Xia and C. Li, Asymmetric formal abnormal Claisen rearrangement enabled by Rh-catalyzed regio- and enantioselective allylic alkylation, ACS Catal., 2023, 13, 5482–5490 CrossRef CAS ; (j) Y. Jiang, Q. Jiang, G. Zhu and X. Zhang, Highly effective NPN-type tridentate ligands for asymmetric transfer hydrogenation of ketones, Tetrahedron Lett., 1997, 38, 215–218 CrossRef CAS .

Footnote

Electronic supplementary information (ESI) available. CCDC 2355497. For ESI and crystallographic data in CIF or other electronic format see DOI: https://doi.org/10.1039/d4qo01474j

This journal is © the Partner Organisations 2024
Click here to see how this site uses Cookies. View our privacy policy here.